The Omics, molecular diagnostics and breakthroughs in drug discovery and therapeutics research

The Drug Discovery and Development Forum 2022 will highlight molecular diagnostics and breakthroughs in drug discovery and therapeutics research.


When: 7th, 8th and 9th December, 2022

Where: Room ES1. 1129 (hybrid: virtual and in-person)

Challenges in Drug Discovery and Clinical Development Forum MUHC McGill University CIHR

 
Bellus Health
Cedar Cancer Foundation
McGill Mi4
McGill Mi4
McGill Faculty of Medicine
Wiley
MUHC Foundation
Avantor
Wisent Biotechnologies
VWR
Millipore Sigma
McGill University
 
McGill Oncology
CIHR
MUHC
 

Meet our speakers

DAY I - COVID-19 DRUGS AND DIAGNOSTICS BREAKTHROUGHS

Professor Jeremy Nicholson

Professor Jeremy Nicholson

Pro-Vice Chancellor of Health Sciences, Murdoch University, Australia, Emeritus Professor Imperial College, London


Presentation Title

Molecular phenomic approach to understanding the natural history of Covid-19

Dr. Matthias Gotte

Dr. Matthias Gotte

Former DDTP mentor, Professor and Chair, Department of Medical Microbiology & Immunology, Faculty of Medicine & Dentistry, Li Ka Shing Institute of Virology, University of Alberta, Canada


Presentation Title

What is new on remdesivir and other covid-19 antiviral treatments

Dr. John W. Gillard

Dr. John W. Gillard

CEO - JNNova Pharma Inc., Adj. Professor, Dept. Pharmacology & Therapeutics, McGill University, Montreal QC


Presentation Title

Design and Development of High-Affinity ACE2 Surrogates as Potent Covid19 Therapeutic Agents

Dr. Eric Hoffman

Dr. Eric Hoffman

Professor, Pharmaceutical Sciences, Binghamton University State University of New York, CEO AGADA BioSciences, CEO ReveraGen BioPharma


Presentation Title

How late should a new drug development program be kept in the academic space? Late-stage exemplars of viltolarsen and vamorolone.

Dr. Suman Rao

Dr. Suman Rao

Former DDTP trainee, Life Science Venture Capital Associate, LUMIRA Ventures Toronto


DAY II MULTIOMICS, DIAGNOSTICS AND TARGETS FOR THERAPEUTIC INTERVENTION

Professor David Goldstein

Professor David Goldstein

Director of the Institute for Genomic Medicine, and Professor of Genetics and Development at Columbia University, Co-Founder of Praxis Precision Medicines, CEO of Actio Biosciences


Presentation Title

Mendelian genes as rare and common disease targets

Dr. Trevor Pugh

Dr. Trevor Pugh

Senior Scientist, Princess Margaret Cancer Centre, Director, Genomics, Ontario Institute for Cancer Research Associate Professor, Department of Medical Biophysics, University of Toronto


Professor Suhad Ali

Professor Suhad Ali

Senior Scientist, RI-MUHC, - Cancer Research Program, Professor, Department of Medicine, Faculty of Medicine and Health Sciences, McGill University, Department of Medicine, Division of Hematology, MUHC


Presentation Title

Prolactin Differentiation Therapy in Breast Cancer

EDUCATIONAL SESSION: SPATIAL OMICS AND METABOLOMICS

Dr. Jianguo (Jeff) Xia

Dr. Jianguo (Jeff) Xia

Associate Professor and Chair, Canada Research in Bioinformatics and Big data Analytics, McGill University, Montreal, Canada


Presentation Title

Metabolomics: from raw LC-MS spectra to biological insights

Dr. Elisabeth Neuman

Dr. Elisabeth Neuman

Assistant Professor, Department of Chemistry, University of California


Presentation Title

Multimodal Mass Spectrometry Imaging Approaches for Probing Complex Biological Systems

Professor Elaine Holmes

Professor Elaine Holmes

Professor of Computational Medicine & Premier's Fellow & Director of Computational & Systems Medicine, Murdoch University, Perth, Australia


Presentation Title

Understanding Microbiome- Metabolic Axis interactions in a healthcare framework

DAY III SYNTHETIC BIOLOGY, SMALL MOLECULES AND NEW THERAPEUTIC STRATEGIES

Dr. Jean-Jacques Lebrun

Dr. Jean-Jacques Lebrun

Professor of Medicine, McGill University Health Center, Cancer Research Program | Molecular and Translational Oncology


Presentation Title

Crisperized Medicine for Precision Oncology

Dr. Katherine Vallis

Dr. Katherine Vallis

Professor of Experimental Radiotherapeutics Group Leader, Oxford Institute for Radiation Oncology Honorary Consultant in Clinical Oncology, Oxford University Hospitals, NHS Trust, UK


Presentation Title

Antibody-based therapeutics against intracellular cancer targets

Dr. Alain Wagner

Dr. Alain Wagner

Directeur de Recherche, CNRS, Université de Strasbourg, UNISTRA - Laboratoire de conception et application de molécules bioactives


Presentation Title

Bioconjugation and more in the field of Antibody Drug Conjugate

Dr. Vincent Mooser

Dr. Vincent Mooser

Canada Excellence Research Chair in Genomic Professor, Department of Human Genetics, Faculty of Medicine, McGill University, Montreal Canada


Presentation Title

Drugging the human genome - The use of germline genomics in drug discovery and precision drug development

Dr. Anne Marinier

Dr. Anne Marinier

Director of Medicinal Chemistry, Institut de recherche en immunologie et en cancérologie (IRIC), Université de Montréal


Presentation Title

Médicament Québec: La Chimiothèque

Dr. Alice Dragomir

Dr. Alice Dragomir

Associate Professor at University of Montreal, Faculty of Pharmacy Associate Member, Department of Surgery, Division of Surgical Research, McGill University
Director, Réseau Québécois de Recherche sur les Médicaments (RQRM)


Presentation Title

Drug Research : preclinical and post marketing considerations


Advisory Committee

Dr. Bertrand J. Jean-Claude

Dr. Janusz Rak

Dr. Bassam Abdulkarim

Dr. Kolja Eppert

Dr. John Dibattista


Forum 2019, a successful event - View photos below:

  • Special educational session on advanced microscopy for drug discovery led by Dr. Min Fu
  • Introduction to hyphenated NMR techniques biochemical / Biomedical applications led by Dr. Robert Hambalek
  • Special educational session on Metabolomics ق€“ From basic concepts to Practical Dta Analysis led by Dr. Jeff Xia
  • Special educational session on Practical Proteomics 
led by Dr. Kurt Dejgaard
  • Special educational session on Matrix and metal assited laser desorption ionization for high spatial resolution imagind led by Dr. Pierre Chaurand
  • Dr. Martine Monette presenting the multidisciplinary CTB Drug Discovery Platform and Bruker collaboration
  • Commercial Exhibit and Poster Presentations
  • Commercial Exhibit and Poster Presentations

Forum 2018, a successful event - View photos below:


Forum 2017, a successful event - View photos below:

  • Special educational session on advanced microscopy for drug discovery led by Dr. Min Fu
  • Special educational session Introduction to hyphenated NMR techniques biochemical / Biomedical applications led by Dr. Robert Hambalek
  • INTERDISCIPLINARY WORKSHOP
  • INTERDISCIPLINARY WORKSHOP
  • Day 3 ق€“ June 14, 2017
  • Symposium III
  • Symposium III
  • Award Ceremony for the oral presentations by trainees
  • Poster session & Commercial exhibit in the Atrium
  • Poster session & Commercial exhibit in the Atrium
  • Poster session & Commercial exhibit in the Atrium

Forum 2016, a successful event - View photos below:

  • 2nd International Drug Discovery and Development Forum 2016
  • Day 3 ق€“ June 8, 2016 ق€“ Symposium II
Animal Models and Translational Research
  • DDay 4 ق€“ June 9, 2016 ق€“ Poster session & Commercial exhibition (Atrium)
  • DDay 4 ق€“ June 9, 2016 ق€“ Poster session & Commercial exhibition (Atrium)
  • Day 4 ق€“ June 9, 2016 ق€“ Poster session & Commercial exhibition (Atrium)I